Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial Letter

Industry Collaboration International Collaboration

cited authors

  • Cosentino, Francesco; Cannon, Christopher P.; Frederich, Robert; Cherney, David Z. I.; Dagogo-Jack, Samuel; Pratley, Richard E.; Mancuso, James P.; Maldonado, Mario; Cater, Nilo B.; Wang, Shuai; McGuire, Darren K.

authors

Publication Date

  • August 23, 2022

webpage

published in

category

keywords

  • cardiovascular diseases
  • diabetes mellitus
  • metformin
  • sodium-glucose transporter 2 inhibitors
  • type 2

start page

  • 652

end page

  • 654

volume

  • 146

issue

  • 8